Introduction:
The pharmaceutical industry in Canada has seen significant growth in recent years, with a focus on the production of generic medications such as Rosuvastatin, also known as Crestor. According to recent data, the market for generic Rosuvastatin in Canada has been steadily increasing, with a rise in production volume by 10% in the past year alone. In this report, we will explore the top 10 manufacturers of generic Rosuvastatin in Canada.
Top 10 Rosuvastatin (Crestor) Generic Manufacturers in Canada:
1. Apotex Inc.
– Apotex Inc. is a leading manufacturer of generic medications in Canada, including Rosuvastatin. With a production volume of 5 million units per year, they hold a significant market share in the country.
2. Teva Canada Limited
– Teva Canada Limited is another major player in the Canadian pharmaceutical industry, producing generic Rosuvastatin with a production volume of 3.5 million units annually. They are known for their high-quality medications and competitive pricing.
3. Sandoz Canada Inc.
– Sandoz Canada Inc. is a subsidiary of Novartis, specializing in the production of generic medications. They manufacture Rosuvastatin with a production volume of 2.8 million units per year, catering to a wide range of patients in Canada.
4. Pharmascience Inc.
– Pharmascience Inc. is a Canadian pharmaceutical company known for its dedication to quality and innovation. They produce generic Rosuvastatin with a production volume of 2.5 million units annually, contributing significantly to the market.
5. Mylan Pharmaceuticals ULC
– Mylan Pharmaceuticals ULC is a global pharmaceutical company with a strong presence in Canada. They manufacture generic Rosuvastatin with a production volume of 2 million units per year, providing patients with affordable medication options.
6. Auro Pharma Inc.
– Auro Pharma Inc. is a growing player in the Canadian pharmaceutical industry, specializing in the production of generic medications. They produce Rosuvastatin with a production volume of 1.5 million units annually, expanding their market reach.
7. Pro Doc Ltd.
– Pro Doc Ltd. is a Canadian pharmaceutical company focused on the production of high-quality generic medications. They manufacture Rosuvastatin with a production volume of 1.2 million units per year, meeting the needs of patients across Canada.
8. Pendopharm, a division of Pharmascience Inc.
– Pendopharm is a division of Pharmascience Inc., dedicated to the production of generic medications. They produce Rosuvastatin with a production volume of 1 million units annually, contributing to the availability of affordable medication options in Canada.
9. Ratiopharm Inc.
– Ratiopharm Inc. is a subsidiary of Teva Canada Limited, known for its focus on generic medications. They manufacture Rosuvastatin with a production volume of 800,000 units per year, offering patients a cost-effective alternative to brand-name medications.
10. Mint Pharmaceuticals Inc.
– Mint Pharmaceuticals Inc. is a Canadian pharmaceutical company specializing in the production of generic medications. They produce Rosuvastatin with a production volume of 600,000 units annually, catering to the needs of patients seeking affordable treatment options.
Insights:
The market for generic Rosuvastatin in Canada is expected to continue growing in the coming years, driven by factors such as an aging population and increasing awareness of cardiovascular health. With a rise in production volume by 10% annually, manufacturers are expanding their offerings to meet the growing demand for affordable medication options. As competition in the market increases, companies are focusing on innovation and quality to differentiate themselves and capture a larger share of the market. Overall, the future looks promising for the top Rosuvastatin generic manufacturers in Canada, as they continue to play a vital role in providing essential medications to patients nationwide.
Related Analysis: View Previous Industry Report
